Substance GP-2250 as a New Therapeutic Agent for Malignant Peritoneal Mesothelioma-A 3-D In Vitro Study.

Int J Mol Sci · 2022 · PMC9267014 · PMID 35806313

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Concerning cytotoxicity, a highly significant reduction of viable cells was measured beginning at 500 μmol/L (JL-1 sph.) and 1000 μmol/L GP-2250 (MSTO-211H sph.) ( Figure 5 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.